Advertisement

Topics

Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (Study P05553)

2014-08-27 03:19:04 | BioPortfolio

Summary

This study will be performed to directly compare the efficacy and safety of the classical "Step-Up" approach for treatment of moderate to severe active ulcerative colitis using prednisolone and 5-aminosalicylic acid (5-ASA) and oral Azathioprine (AZA) with a more intensive and early "Top-Hold" approach with infliximab (5 mg/kg) continuously given every 8 weeks following induction at weeks 0, 2, and 6.

Investigational Medical Product: Infliximab at 5 mg/kg body weight intravenously (IV) for induction and maintenance treatment given at week 0,2,6, followed by q8w (Level 1) and q4w (Level 2) weeks through week 46. Non responders in Level 2 will be switched to prednisolone combined with AZA (oral Azathioprine) (Level 3).

Reference Products: Level 1: Oral prednisolone (40 mg/day or 1mg/kg/day in case of non-response) and oral 5-ASA (2 g/day); Level 2: Oral prednisolone (40 mg/day or 1 mg/kg/day in case of non-response) and oral AZA at a dose of 2.0 - 2.5 mg/kg/day. Non-responders in Level 2 will enter Level 3: Infliximab at 5 mg/kg. The reference therapy in Levels 1 and 2 will be administered daily up to week 50, or in Level 3 infliximab q8w through week 46.

Study Design

Allocation: Randomized, Control: Active Control, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Conditions

Colitis, Ulcerative

Intervention

Infliximab, Prednisolone, 5-aminosalicylic acid (5-ASA), Azathioprine (AZA)

Location

Investigational Site 44
Amberg
Germany
92224

Status

Recruiting

Source

Schering-Plough

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T03:19:04-0400

Clinical Trials [1739 Associated Clinical Trials listed on BioPortfolio]

Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis

OBJECTIVES: I. Assess the safety and efficacy of 4-aminosalicylic acid in patients with mildly to moderately severe ulcerative colitis.

Two Therapeutic Strategies for the Maintenance of Remission in Patients With Ulcerative Colitis

Ulcerative colitis patients treated with Infliximab (IFX) in deep remission after at least 12 months of treatment will be randomized to continue IFX or to stop IFX and start Azathioprine (...

Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis

The role of steroids in the treatment of ulcerative Colitis (UC) is well established, and recommended by professional societies. However, there are no data investigating whether the additi...

Aminosalicylic Acid Withdrawal Study in Long Standing Inactive Ulcerative Colitis

The purpose of this study is to determine whether aminosalicylic acid (ASA) can be safely withdrawn in patients with long-standing clinical inactive UC.

Beneficial and Harmful Effects of Azathioprine and Allopurinol Versus Standard Azathioprine Therapy for Patients With Ulcerative Colitis

Azathioprine is considered first line immunomodulatory therapy for patients with ulcerative colitis. Up to 50% are treatment failures or experience adverse events leading to treatment with...

PubMed Articles [7189 Associated PubMed Articles listed on BioPortfolio]

Fecal microbiota transplantation treatment for refractory ulcerative colitis with allergy to 5-aminosalicylic acid: A case report.

Fecal microbiota transplantation (FMT) is currently being explored as a potential therapy for ulcerative colitis (UC). Here, we report the first case of a UC patient with allergy to 5-aminosalicylic a...

5-ASA to sulfasalazine drug switch program in patients with ulcerative colitis.

To switch patients with ulcerative colitis (UC) from costlier 5-aminosalicylic acid compounds to sulfasalazine and assess (1) the cost savings, (2) the barriers to switching, and (3) adverse events (A...

Accelerated Infliximab Dosing Increases 30-Day Colectomy in Hospitalized Ulcerative Colitis Patients: A Propensity Score Analysis.

Standard outpatient induction dosing of infliximab (IFX) may not be effective in hospitalized ulcerative colitis (UC) patients with higher inflammatory burden and colectomy risk. Our aim was to determ...

Infliximab as rescue treatment in a Sweet's Syndrome related to corticodependent ulcerative colitis.

Effect of Accelerated infliximab induction on short- and long-term outcomes of acute severe ulcerative colitis: A retrospective multi-center study and meta-analysis.

In patients with acute severe ulcerative colitis (ASUC), standard infliximab induction therapy has modest efficacy. There are limited data on the short-term or long-term efficacy of accelerated inflix...

Medical and Biotech [MESH] Definitions

Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.

Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.

An acute form of MEGACOLON, severe pathological dilatation of the COLON. It is associated with clinical conditions such as ULCERATIVE COLITIS; CROHN DISEASE; AMEBIC DYSENTERY; or CLOSTRIDIUM ENTEROCOLITIS.

A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS.

A surgical procedure involving the excision of the COLON and RECTUM and the formation of an ILEOANAL RESERVOIR (pouch). In patients with intestinal diseases, such as ulcerative colitis, this procedure avoids the need for an OSTOMY by allowing for transanal defecation.

More From BioPortfolio on "Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (Study P05553)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial